Exchange Announcement • 21 Sep 2026 11:49
Material Business Matters Related to Investment Decisions(Approval of IND Amendment (Part 1&2) for CTP44 (Darzalex Biosimilar) Phase 3 Clinical Trial in Europe)
Exchange Announcement • 16 Sep 2026 08:26
Retirement of Stocks
Exchange Announcement • 07 Sep 2026 08:13
Material Business Matters Related to Investment Decisions(Approval of IND Amendment for CTP51 (Keytruda Biosimilar) Phase 3 Clinical Trial in the U.S.)
Exchange Announcement • 07 Sep 2026 08:13
Material Business Matters Related to Investment Decisions(Approval of IND Amendment for CTP44 (Darzalex Biosimilar) Phase 3 Clinical Trial in Korea)
Exchange Announcement • 07 Sep 2026 07:39